OTLK
OUTLOOK THERAPEUTICS INC
NASDAQ: OTLK · HEALTHCARE · BIOTECHNOLOGY
$0.25
-2.50% today
Updated 2026-04-30
Market cap
$34.41M
P/E ratio
—
P/S ratio
167.29x
EPS (TTM)
$-2.89
Dividend yield
—
52W range
$0 – $3
Volume
3.6M
OUTLOOK THERAPEUTICS INC (OTLK) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.02M | $-27.48M | $-45.48M | $-15.51M | $-33.04M | $-32.29M | $-31.79M | $-54.25M | $-56.67M | $-42.97M | $-68.79M | $-51.83T |
| Capital expenditures | $2.37M | $8.80M | $1.10M | $292086.00 | $2.78M | $437307.00 | $3.00 | $0.00 | $0.00 | $2.00 | $0.00 | $3.00 |
| Depreciation | $878477.00 | $1.82M | $2.39M | $2.69M | $-3.05M | $3.36M | $554069.00 | $262140.00 | $204694.00 | $44188.00 | $113859.00 | $117.05B |
| Stock-based comp | $3.96M | $11.18M | $12.45M | $8.57M | $1.99M | $1.31M | $2.81M | $4.89M | $7.71M | $5.55M | $5.39M | $8.90T |
| Free cash flow | $-9.39M | $-36.28M | $-46.58M | $-15.80M | $-35.82M | $-32.73M | $-31.79M | $-54.25M | $-56.67M | $-42.97M | $-68.79M | $-51.83T |
| Investing cash flow | $-2.37M | $-8.80M | $-1.10M | $-292086.00 | $-2.78M | $-437307.00 | $-900000.00 | — | — | — | — | — |
| Financing cash flow | $11.47M | $43.00M | $39.86M | $16.63M | $34.35M | $39.03M | $37.21M | $56.19M | $59.59M | $48.97M | $60.33M | $44.98T |
| Dividends paid | $8.71M | $10.88M | — | $16.98B | $1.89T | $624.99B | $166.13B | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-6.72M | $833632.00 | $-1.47M | $6.30M | $4.52M | $1.94M | $2.92M | — | — | — |